Evidence map›Paper›PMID 42070170›Full record

ArticleArchives of virology2026

A V2-SKP1 interface in soybean stay-green associated virus: evidence from evolutionary and structural analyses.

Saqib Ali

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Saqib AliDepartment of Plant Pathology, University of Agriculture Faisalabad, Faisalabad, 38000, Pakistan. saqibalilogan223@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Soybean stay-green associated virus (SoSGV) is an emerging begomovirus associated with severe disease in soybean crops in East Asia. This study investigated its evolutionary relationships, population structure, recombination history, adaptive signal, and candidate host-interaction features using integrated phylogenetic, population genetic, natural selection, and structural modeling analyses of 54 complete genome sequences. Maximum-likelihood and Bayesian phylogenetic analyses recovered SoSGV as a distinct monophyletic lineage, with strong support in the maximum-likelihood analysis (96% bootstrap support). Population genetic analysis revealed high haplotype diversity (Hd = 0.962), moderate nucleotide diversity (π = 0.022), and a negative Tajima's D value (D = - 1.49, p < 0.05), a pattern consistent with recent demographic expansion but not, by itself, proof of emergence timing. Recombination screening identified two robust coat protein-associated events (best p = 1.95 × 10⁻⁷ and 1.91 × 10⁻¹⁴), and sliding-window similarity analysis independently supported the resulting mosaic structure. Natural selection analyses detected adaptive signal in the V2 gene; MEME identified episodic selection at residues 35 and 36 (p < 0.1), while complementary methods supported additional method-dependent signals. ColabFold predicted a moderate-confidence V2 structure (mean pLDDT = 73.36). Protein docking identified a plausible V2-SKP1-related interface comprising 39 contacting residues, while a short 10 ns molecular dynamics simulation indicated preliminary structural compatibility rather than biological validation. These findings support the hypothesis that recombination contributed to SoSGV diversification and that V2 may interact with SKP1-related host proteins.

Indexed as

BegomovirusCapsid ProteinsEvolution, MolecularGlycine maxPlant DiseasesAmino Acid SequenceGenetic VariationGenome, ViralModels, MolecularPhylogenyRecombination, GeneticSelection, GeneticCapsid Proteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.